Log In
Print this Print this

Orazol (MER 101)

  Manage Alerts
Collapse Summary General Information
Company Merrion Pharmaceuticals plc
DescriptionOnce-weekly oral formulation of zoledronic acid
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today